Latest research

Stay up to date with the latest advancements in medical imaging, radiotherapy, nuclear medicine and clinical oncology. This section highlights recently published research, innovative clinical studies and emerging technologies that are shaping patient care and professional practice. Explore the findings, insights and developments that are driving progress across the imaging and oncology community.

The content on this page is provided by the individuals concerned and does not represent the views or opinions of RAD Magazine.

Real-world results confirm benefit of PSMA therapy for prostate cancer

Prostate-specific membrane antigen (PSMA)-targeted radiopharmaceutical therapy is safe and effective for patients with metastatic castration-resistant prostate cancer (mCRPC) in routine clinical practice, consistent with outcomes from the landmark VISION trial. An analysis of outcomes from a French early-access program, the largest real-world cohort of patients studied to date, confirms the benefit-risk profile of the therapy, […]

Read More

Molecular imaging demonstrates promise for predicting complete pathologic response in HER2-positive breast cancer

Molecular imaging with 68Ga-HER2 PETCT may provide an early, targeted measure of how well treatment is working in patients with HER2-positive breast cancer. According to new research published in the October issue of The Journal of Nuclear Medicine, 68Ga-HER2 PETCT can detect changes in HER2-positive breast cancer after only two cycles of neoadjuvant treatment, enabling […]

Read More

Proven radiotracer highly effective in detecting rare, aggressive kidney cancer

Renal medullary carcinoma (RMC) demonstrates strong uptake of the radiotracer 18F-FDG, distinguishing it from other types of kidney cancer which often have more variable uptake. 18F-FDG PETCT was found to be highly effective even after systemic treatment and detected additional metastases missed by conventional anatomic imaging, providing a more complete picture of how far the […]

Read More

PSMA PETCT-targeted biopsy improves detection of clinically significant prostate cancer

PSMA PETCT-targeted biopsy detects more clinically significant prostate cancer than systematic biopsy alone in men whose MRI findings are negative or inconclusive yet have persistent clinical risk factors. According to new research published in the September issue of The Journal of Nuclear Medicine, combining the two biopsy approaches is even more effective, nearly doubling the […]

Read More

PETMR improves presurgical lesion detection in paediatric epilepsy

In children with difficulty-to-diagnose epilepsy, PETMR can pinpoint areas of the brain responsible for seizures, even when MRI scans are negative or inconclusive. A new study of a large paediatric cohort, including children younger than six years old, found that combining PETMR findings with EEG results and a structured presurgical evaluation improved the identification of […]

Read More

New paper outlines growing role of interventional radiology in liver cancer treatment

Interventional radiologists (IRs) provide patients with primary and secondary liver cancer with high-quality, high-impact care in a more cost-efficient way than other specialties, according to a study published online in the Journal of Vascular and Interventional Radiology today. The study, funded by the Society of Interventional Radiology (SIR), reviewed Medicare data from 2016–2021 covering approximately […]

Read More

UNC researchers develop technique to silence MRI noise

The innovation may help improve the fMRI experience for patients, while expanding opportunities for brain research. Functional magnetic resonance imaging, or fMRI, gives researchers a powerful way to study brain activity. But the scans can be incredibly noisy for patients and research subjects, with peak sound levels reaching 120 to 138 decibels — about as […]

Read More